Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.6K Sell
1,048
-271
-21% -$18.1K 0.01% 553
2026
Q1
$82.8K Buy
1,319
+1,108
+525% +$77.2K 0.01% 545
2025
Q4
$14K Sell
211
-858
-80% -$55.5K ﹤0.01% 1219
2025
Q3
$71.9K Buy
+1,069
New +$84.6K 0.02% 649
2025
Q1
Sell
-1,283
Closed -$99.8K 1721
2024
Q4
$99.8K Sell
1,283
-3,305
-72% -$245K 0.01% 444
2024
Q3
$308K Buy
4,588
+4,538
+9,076% +$373K 0.08% 185
2024
Q2
$5.67K Sell
50
-3,812
-99% -$482K ﹤0.01% 1470
2024
Q1
$536K Buy
3,862
+3,597
+1,357% +$452K 0.1% 142
2023
Q4
$32.9K Sell
265
-551
-68% -$56.3K 0.01% 499
2023
Q3
$76.1K Buy
816
+634
+348% +$71.5K 0.02% 241
2023
Q2
$23.4K Buy
182
+60
+49% +$7.26K 0.01% 511
2023
Q1
$14.2K Buy
+122
New +$13.7K ﹤0.01% 753

Other funds holding DXCM

Quarry LP's DXCM Position: Q2 2026 in Review

Quarry LP reduced its DexCom (DXCM) stake by 21% in Q2 2026, selling an estimated $18.1K and leaving 1,048 shares worth $70.6K. The position accounts for 0.01% of the portfolio, ranked #553.

Quarry LP first reported a position in DXCM in Q1 2023 and has held it in 12 quarters since. The position peaked at $536K in Q1 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Quarry LP held 1,048 shares of DexCom worth $70.6K as of Q2 2026.
  • Quarry LP sold 271 DexCom shares in Q2 2026, an estimated $18.1K.
  • DexCom made up 0.01% of Quarry LP's portfolio in Q2 2026, its #553 holding.
  • Quarry LP first reported a position in DexCom in Q1 2023 and has held it in 12 quarters since.
  • Quarry LP's DexCom position peaked at $536K in Q1 2024.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.